Additionally, gene expression from the peripheral blood mononucleated cell (PBMC) culture treated with IL-33 was overlapped with RRMS patients, suggesting that the gene expression observed in RRMS was perhaps regulated by IL-33-mediated immune pathways. This evidence concerns the gene IL33 and relapsing-remitting multiple sclerosis.